MXPA05004849A - Novedosas composiciones de multiples peptidos antigenicos relacionados con inhibina, que mejoran el desempeno de produccion avicola. - Google Patents

Novedosas composiciones de multiples peptidos antigenicos relacionados con inhibina, que mejoran el desempeno de produccion avicola.

Info

Publication number
MXPA05004849A
MXPA05004849A MXPA05004849A MXPA05004849A MXPA05004849A MX PA05004849 A MXPA05004849 A MX PA05004849A MX PA05004849 A MXPA05004849 A MX PA05004849A MX PA05004849 A MXPA05004849 A MX PA05004849A MX PA05004849 A MXPA05004849 A MX PA05004849A
Authority
MX
Mexico
Prior art keywords
inhibin
avians
production performance
novel
enhance production
Prior art date
Application number
MXPA05004849A
Other languages
English (en)
Inventor
Daniel G Satterlee
Original Assignee
Agritech Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agritech Technology Ltd filed Critical Agritech Technology Ltd
Publication of MXPA05004849A publication Critical patent/MXPA05004849A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
    • A61K2039/645—Dendrimers; Multiple antigen peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)

Abstract

La presente invencion proporciona composiciones de materia novedosas que comprenden composiciones MAP que comprenden al menos 2 peptidos relacionados a inhibina enlazados a una estructura principal. Estas composiciones son inmunogenicas y mejoran el desempeno de produccion cuando se administran junto con un portador aceptable a los animales, en especial aves.
MXPA05004849A 2002-11-07 2003-11-07 Novedosas composiciones de multiples peptidos antigenicos relacionados con inhibina, que mejoran el desempeno de produccion avicola. MXPA05004849A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42461802P 2002-11-07 2002-11-07
PCT/US2003/035626 WO2004043141A2 (en) 2002-11-07 2003-11-07 Novel inhibin-related multiple antigenic peptide compositions that enhance production performance in avians

Publications (1)

Publication Number Publication Date
MXPA05004849A true MXPA05004849A (es) 2006-03-08

Family

ID=32312842

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05004849A MXPA05004849A (es) 2002-11-07 2003-11-07 Novedosas composiciones de multiples peptidos antigenicos relacionados con inhibina, que mejoran el desempeno de produccion avicola.

Country Status (7)

Country Link
US (1) US20060188513A1 (es)
EP (1) EP1567542A4 (es)
JP (1) JP2006523180A (es)
AU (1) AU2003295420A1 (es)
BR (1) BR0316084A (es)
MX (1) MXPA05004849A (es)
WO (1) WO2004043141A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY141073A (en) 2003-05-02 2010-03-15 Almar Packaging Internat Inc Intermediate bulk container
DK2352508T3 (da) 2008-10-17 2014-04-28 Dana Farber Cancer Inst Inc Muc-1 cytoplasmisk domæne-peptider som inhibitorer af cancer
JP2012522021A (ja) * 2009-03-30 2012-09-20 元森泰生物科技（天津）有限公司 合成ペプチド及びその応用
BR102014005376A2 (pt) * 2014-03-07 2016-02-10 Ouro Fino Saúde Animal Ltda antígeno de inibina alfa, gene codificante de inibina alfa, gene codificante de proteína de fusão, processo de obtenção do antígeno de inibina alfa, composição antigênica, uso do antígeno de inibina alfa e uso da composição antigênica
CN110408623B (zh) * 2019-07-08 2021-08-31 扬州大学 一种提高鹅产蛋性能的方法
CN116375844B (zh) * 2023-02-22 2024-03-29 四川农业大学 一种抑制素抗原肽及其疫苗和制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4864019A (en) * 1985-11-08 1989-09-05 The Salk Institute For Biological Studies Antibodies to inhibin and conjugates produced therefrom
US5015729A (en) * 1986-06-24 1991-05-14 The Salk Institute For Biological Studies Ovine inhibin
WO1995022980A1 (en) * 1994-02-28 1995-08-31 Agritech Technologies, Ltd. Inhibin compositions and methods of use thereof
IL126874A0 (en) * 1998-11-03 1999-09-22 Federman & Sons Holdings Ltd A new composition and method for increasing production yield of mammalian species

Also Published As

Publication number Publication date
JP2006523180A (ja) 2006-10-12
EP1567542A4 (en) 2006-12-27
BR0316084A (pt) 2005-09-27
WO2004043141A3 (en) 2005-01-13
WO2004043141A2 (en) 2004-05-27
AU2003295420A1 (en) 2004-06-03
EP1567542A2 (en) 2005-08-31
US20060188513A1 (en) 2006-08-24

Similar Documents

Publication Publication Date Title
EP2360259A3 (en) Promyostatin peptides and methods of using same
AU1593001A (en) Recombinant gelatin in vaccines
NO20100324L (no) Fremgangsmate for trinnvis festing av polyetylenglykol (PEG) andeler i serie til et polypeptid
CO5700784A2 (es) Polipeptidos de virus de papiloma humano y composiciones in- munogenas
ATE280826T1 (de) Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen
ATE177757T1 (de) Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17
BG102714A (en) Pharmaceutical composition for immunomodulation based on peptides and adjuvants
NZ335485A (en) Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
DE60204714D1 (de) Pharmakologische nahrungszusammensetzung zur nahrungsergängzung und nährwertverbesserung
EP1277762A3 (en) Low allergenic protein variants
WO2002064057A3 (en) Use of cell penetrating peptides to generate antitumor immunity
HK1029124A1 (en) Lh-rh peptide analogues, their uses and pharmaceutical compositions containing them.
EP2316479A3 (en) Pharmaceutical compositions comprising immunologically active herpes simplex virus (HSV) protein fragments
DE60120712D1 (en) Kallikrein gen
ES2193216T3 (es) Dipeptidil peptidasa iv y su procedimiento de preparacion.
BG106008A (en) Novel lhrh antagonists with improved solubility characteristics
HRP20040278B1 (en) Gonadotrophins for folliculogenesis
MXPA05004849A (es) Novedosas composiciones de multiples peptidos antigenicos relacionados con inhibina, que mejoran el desempeno de produccion avicola.
AU4653301A (en) Anti-freeze proteins, their production and use
GB9914045D0 (en) Novel compounds
DE602004028266D1 (de) Angiogene peptide und ihre verwendungen
HK1071079A1 (en) Use of soluble fgl2 as an immunosuppressant
EA200100395A1 (ru) Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием
WO2003068815A3 (en) Mhc class ii peptide epitope of 5t4 antigen
WO2000012122A3 (de) Niedermolekulare fragmente der hyaluronsäure zur herstellung von impfstoffen